Clinical Trials
Closed
Phase
Accrual
84%
Published
SWOG Clinical Trial Number
SWOG-9333
A Randomized Controlled Trial of Mitoxantrone and Etoposide versus Daunomycin and Cytosine Arabinoside as Induction Therapy in Patients Over Age 55 With Previously Untreated Acute Myeloid Leukemia, Phase III
Research Committee(s)
Leukemia
Activated
01-15-1995
Closed
12-01-1998
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
SWOG-9443 (NABTC-9402) (NCI T94-0087)
A Phase II Trial of Phenylacetic Acid for Recurrent Malignant Glioma and Primitive Neuroectodermal Tumors: A Clinical and Pharmacokinetics Study of the North American Brain Tumor Consortium
Research Committee(s)
Brain Cancer
Activated
12-27-1994
Closed
12-15-1997
Closed
Phase
Accrual
31%
Published
SWOG Clinical Trial Number
SWOG-9405
Adequacy Conventional Radiation Therapy Portals to Encompass Locally Advanced Cervix Cancer: An Ancillary Study to SWOG-9318
Activated
12-15-1994
Closed
03-01-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9338
A Phase II Trial of Combination Therapy With 5-Fluorouracil, a-Interferon and Interleukin-2 ("FUNIL") for Advanced Renal Cell Carcinoma
Research Committee(s)
Genitourinary Cancer
Activated
12-15-1994
Closed
09-01-1997
Closed
Phase
Accrual
98%
Published
SWOG Clinical Trial Number
SWOG-9318
Recombinant Human Erythropoietin (r-HuEPO) as an Adjunct to Radiation Therapy and Cisplatin for Patients with Stages II-B, III and IV-A Carcinoma of the Cervix, Phase II
Research Committee(s)
Gynecologic Cancer
Activated
12-15-1994
Closed
03-01-1999
Closed
Phase
Accrual
71%
Published
SWOG Clinical Trial Number
SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)
Phase III Randomized Trial of 5-FU/Leucovorin/Levamisole versus 5-FU Continuous Infusion/Levamisole as Adjuvant Therapy for High-Risk Resectable Colon Cancer, Intergroup.
Research Committee(s)
Gastrointestinal Cancer
Activated
12-01-1994
Closed
12-15-1999
Closed
Phase
Accrual
75%
Published
SWOG Clinical Trial Number
SWOG-9424
Phase II Trial of High Dose Tamoxifen Plus Cisplatin Chemotherapy in Metastatic Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
11-15-1994
Closed
12-01-1996
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9341
High-Dose Ifosfamide (HDI) with Mesna and Granulocyte-Colony Stimulating Factor (rhG-CSF) in Unresectable Malignant Mesothelioma
Activated
09-15-1994
Closed
09-15-1996
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9349
A Randomized Phase II Trial of CHOP with G-CSF Support or ProMACE-CytaBOM with G-CSF Support for Treatment of Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
09-15-1994
Closed
01-15-1997
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9429
Phase II Trial of Carboplatin and VP-16 With Concurrent For Poor-Risk Stage III Non-Small Cell Lung Carcinoma
Research Committee(s)
Lung Cancer
Activated
08-15-1994
Closed
09-01-1995
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9343
Evaluation of Combined Androgen Suppression and Fixed Schedule Suramin in Patients with Newly Diagnosed Metastatic Prostate Cancer, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
08-15-1994
Closed
01-15-1997
Closed
Phase
Accrual
49%
Published
SWOG Clinical Trial Number
SWOG-9219
A Phase II Evaluation of Interleukin-4 (IL-4) in Patients with Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
08-01-1994
Closed
08-01-1999
Closed
Phase
Accrual
39%
Published
SWOG Clinical Trial Number
SWOG-9350
Limited Institution Pilot Trial of Alpha Interferon with Combination Chemotherapy in Disseminated Malignant Melanoma, Phase II
Research Committee(s)
Melanoma
Activated
08-01-1994
Closed
11-13-1996
Closed
Phase
Accrual
4%
SWOG Clinical Trial Number
SWOG-9328 (ECOG-S9328)
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9212
Phase II Trial of Oral Etoposide in Recurrent or Refractory Endometrial Adenocarcinoma
Research Committee(s)
Gynecologic Cancer
Activated
05-15-1994
Closed
01-15-1997
Closed
Phase
Accrual
36%
SWOG Clinical Trial Number
SWOG-9428
Evaluation of DNA Ploidy and p53 in Patients Registered to SWOG-8794 and SWOG-9024, Ancillary
Research Committee(s)
Genitourinary Cancer
Activated
05-15-1994
Closed
12-01-1999
Closed
Phase
Accrual
89%
Published
SWOG Clinical Trial Number
SWOG-9149
A Phase II Study of Cisplatin Preceded by a 12-Hour Continuous Infusion of Concurrent Hydroxyurea and Cytosine Arabinoside (Ara-C) for Adult Patients with Malignant Gliomas
Research Committee(s)
Brain Cancer
Activated
05-01-1994
Closed
02-15-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9320
Study of ProMACE-CytaBOM with Trimethoprim Sulfamethoxazole, Granulocyte Colony Stimulating Factor (G-CSF) and Antiretroviral Therapy in Patients with AIDS Related Lymphoma, Phase II
Research Committee(s)
Lymphoma
Activated
05-01-1994
Closed
12-01-2000
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-9418
A Pilot Study Evaluating an Educational Program to Increase Utilization of Cervical and Breast Cancer Screening Methods in Hispanic Women
Activated
05-01-1994
Closed
01-01-1996
Closed
Phase
Accrual
85%
Published
SWOG Clinical Trial Number
SWOG-9348
Evaluation of the Standard BCNU/DTIC/Cisplatin/Tamoxifen Regimen in Disseminated Malignant Melanoma, Phase II
Research Committee(s)
Melanoma
Activated
04-15-1994
Closed
04-15-1995